DK1438420T3 - Fremgangsmåder til anvendelse af kvantitative lipid-metablom-data - Google Patents
Fremgangsmåder til anvendelse af kvantitative lipid-metablom-dataInfo
- Publication number
- DK1438420T3 DK1438420T3 DK02782079.4T DK02782079T DK1438420T3 DK 1438420 T3 DK1438420 T3 DK 1438420T3 DK 02782079 T DK02782079 T DK 02782079T DK 1438420 T3 DK1438420 T3 DK 1438420T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- data
- metaboma
- lipid
- markers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32472801P | 2001-09-24 | 2001-09-24 | |
US35212902P | 2002-01-25 | 2002-01-25 | |
PCT/US2002/030348 WO2003028271A2 (en) | 2001-09-24 | 2002-09-24 | Methods of using quantitative lipid metabolome data |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1438420T3 true DK1438420T3 (da) | 2010-01-18 |
Family
ID=26984604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02782079.4T DK1438420T3 (da) | 2001-09-24 | 2002-09-24 | Fremgangsmåder til anvendelse af kvantitative lipid-metablom-data |
Country Status (8)
Country | Link |
---|---|
US (2) | US20050009005A1 (da) |
EP (1) | EP1438420B1 (da) |
AT (1) | ATE443264T1 (da) |
AU (1) | AU2002348574A1 (da) |
CA (1) | CA2459508A1 (da) |
DE (1) | DE60233743D1 (da) |
DK (1) | DK1438420T3 (da) |
WO (1) | WO2003028271A2 (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1490076A4 (en) * | 2002-03-11 | 2010-01-06 | Lipomics Technologies Inc | NEW METABOLIC TARGETS AND MARKERS |
WO2006031963A2 (en) * | 2004-09-13 | 2006-03-23 | Lipomics Technologies, Inc. | Metabolite markers for weight management |
US8637321B2 (en) * | 2005-10-24 | 2014-01-28 | Duke University | Lipidomics approaches for central nervous system disorders |
NZ594178A (en) * | 2006-02-27 | 2013-02-22 | Targeted Molecular Diagnostics Llc | An ex vivo method of predicting toxicity to tyrosine kinase inhibitors |
DE602007011588D1 (de) * | 2006-03-24 | 2011-02-10 | Metanomics Gmbh | MITTEL UND VERFAHREN ZUR PROGNOSE ODER DIAGNOSE VON DIABETES Typ II |
US8137977B2 (en) * | 2006-04-24 | 2012-03-20 | Children's Hospital & Research Center At Oakland | Lipidomic approaches to determining drug response phenotypes in cardiovascular disease |
US8232065B2 (en) * | 2006-05-08 | 2012-07-31 | Tethys Bioscience, Inc. | Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets |
EP2029771A4 (en) | 2006-06-12 | 2010-08-04 | Zora Biosciences Oy | DIAGNOSTIC METHOD OF MYOPATHY |
EP2607902B1 (en) * | 2006-08-08 | 2017-10-04 | Metabolon, Inc. | Markers of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and methods of use thereof |
CN101802620A (zh) * | 2007-02-22 | 2010-08-11 | 特提斯生物科学公司 | 糖尿病状况的代谢标志物及其使用方法 |
JPWO2009142242A1 (ja) * | 2008-05-20 | 2011-09-29 | 持田製薬株式会社 | ハイリスク患者の心血管イベント予防用組成物 |
BRPI0912136A2 (pt) * | 2008-05-28 | 2015-11-03 | Basf Se | métodos para diagnosticar proliferação peroxissomal aumentada e para identificar uma substância para tratar proliferação peroxissomal aumentada, e, uso de pelo menos cinco analitos e de meios para a determinação de pelo menos cinco analitos |
WO2010028336A2 (en) * | 2008-09-08 | 2010-03-11 | President And Fellows Of Harvard College | Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status |
WO2011063470A1 (en) * | 2009-11-27 | 2011-06-03 | Baker Idi Heart And Diabetes Institute Holdings Limited | Lipid biomarkers for stable and unstable heart disease |
WO2011140296A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles as inhibitors of fatty acid synthase |
CA2798330A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals, Inc. | Tetrazolones as inhibitors of fatty acid synthase |
WO2012051463A2 (en) * | 2010-10-14 | 2012-04-19 | The Regents Of The University Of California | Urine metabolomic profile of diabetic kidney disease |
CN102789536B (zh) * | 2011-05-20 | 2015-11-18 | 中国人民解放军第二军医大学 | 肝脏手术治疗风险无创评估模型的建立方法 |
WO2014143080A1 (en) * | 2013-03-15 | 2014-09-18 | Beyond Obesity Llc | Methods for generating personalized dietary guidance using fatty acids for purposes of reducing risk of pathology |
MX2016008045A (es) * | 2013-12-20 | 2016-10-12 | Metabolon Inc | Biomarcadores de lipogenesis de novo y metodos de uso de los mismos. |
EP3362060A4 (en) * | 2015-10-18 | 2019-06-19 | Wei Jia | BIOMARKERS ASSOCIATED WITH DIABETES AND DISEASE TREATMENT ASSOCIATED WITH DIABETES |
US20180180633A1 (en) * | 2016-12-23 | 2018-06-28 | Virta Health Corp. | Methods of rationally designing a personalized nutritional plan |
KR102163693B1 (ko) * | 2018-09-27 | 2020-10-12 | 차의과학대학교 산학협력단 | 노화 및 항노화 바이오마커 및 그의 용도 |
CN112255333B (zh) * | 2020-09-28 | 2022-07-22 | 复旦大学 | 卵巢肿瘤尿液代谢标志物及其应用 |
WO2023137449A2 (en) * | 2022-01-13 | 2023-07-20 | Purdue Research Foundation | Methods of assessing carcass muscle biomarkers to discriminate characteristics of the meat |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3847550A (en) * | 1973-03-27 | 1974-11-12 | Atomic Energy Commission | Differential chromatographic method |
US5075101A (en) * | 1990-04-10 | 1991-12-24 | Siguel Edward N | Method for diagnosis of fatty acid or lipid abnormalities |
US5773300A (en) * | 1995-05-18 | 1998-06-30 | Cell Therapeutics, Inc. | Neoplasia diagnostic method |
ATE264523T1 (de) * | 1997-07-25 | 2004-04-15 | Affymetrix Inc A Delaware Corp | Verfahren zur herstellung einer bio-informatik- datenbank |
US6223127B1 (en) * | 1997-08-15 | 2001-04-24 | Affymetrix, Inc. | Polymorphism detection utilizing clustering analysis |
US6185561B1 (en) * | 1998-09-17 | 2001-02-06 | Affymetrix, Inc. | Method and apparatus for providing and expression data mining database |
AU2054000A (en) * | 1999-02-26 | 2000-09-14 | Lipomed, Inc. | Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood |
CA2452660A1 (en) * | 2001-07-06 | 2003-01-16 | Lipomics Technologies, Inc. | Generating, viewing, interpreting, and utilizing a quantitative database of metabolites |
EP1490076A4 (en) * | 2002-03-11 | 2010-01-06 | Lipomics Technologies Inc | NEW METABOLIC TARGETS AND MARKERS |
-
2002
- 2002-09-24 CA CA002459508A patent/CA2459508A1/en not_active Abandoned
- 2002-09-24 EP EP02782079A patent/EP1438420B1/en not_active Revoked
- 2002-09-24 WO PCT/US2002/030348 patent/WO2003028271A2/en not_active Application Discontinuation
- 2002-09-24 DE DE60233743T patent/DE60233743D1/de not_active Expired - Lifetime
- 2002-09-24 DK DK02782079.4T patent/DK1438420T3/da active
- 2002-09-24 AU AU2002348574A patent/AU2002348574A1/en not_active Abandoned
- 2002-09-24 AT AT02782079T patent/ATE443264T1/de not_active IP Right Cessation
-
2004
- 2004-03-24 US US10/808,880 patent/US20050009005A1/en not_active Abandoned
-
2008
- 2008-11-14 US US12/271,809 patent/US20090239253A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2459508A1 (en) | 2003-04-03 |
DE60233743D1 (de) | 2009-10-29 |
EP1438420A2 (en) | 2004-07-21 |
WO2003028271A9 (en) | 2004-06-24 |
EP1438420A4 (en) | 2006-09-06 |
EP1438420B1 (en) | 2009-09-16 |
WO2003028271A3 (en) | 2004-04-01 |
US20090239253A1 (en) | 2009-09-24 |
ATE443264T1 (de) | 2009-10-15 |
US20050009005A1 (en) | 2005-01-13 |
WO2003028271A2 (en) | 2003-04-03 |
AU2002348574A1 (en) | 2003-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1438420T3 (da) | Fremgangsmåder til anvendelse af kvantitative lipid-metablom-data | |
WO2005079312A3 (en) | Automated system and method for determination and reporting of business development opportunities | |
FI20041323A (fi) | Analysoija, järjestelmä ja menetelmä toivotun käyttäjäjoukon määrittämiseksi | |
UY29720A1 (es) | Medidor con interfaz de usuario de niveles multiples | |
ATE372289T1 (de) | Messstreifenspenderanordnung | |
ATE550649T1 (de) | Testvorrichtung für analyten mit vielseitiger verwendungsmöglichkeit | |
DE60140600D1 (de) | Elektrochemischer teststreifen zur verwendung bei der analyten-bestimmung | |
BRPI0606832A2 (pt) | mostrador icÈnico de marcadores para um medidor | |
BR112014016232A2 (pt) | medições precisas de analito para tira de teste eletroquímico com base em múltiplas medições discretas definidas pela(s) característica(s) física(s) detectada(s) da amostra contendo o analito | |
IS7611A (is) | Örfylki og aðferð til þess að framkvæma blöndunarhvörf fyrir fjölda sýna á einu örfylki | |
BRPI0413975A (pt) | métodos para identificar uma medição imprecisa entre uma pluralidade de medição e para detectar e identificar uma medição imprecisa entre uma pluralidade de medição por gps, e, meio legìvel por computador | |
IN2014DN02241A (da) | ||
AU2002359891A1 (en) | Test strip for determining concentration of triglycerides | |
WO2006090132A8 (en) | Method of assessing energy efficiency of buildings | |
WO2005074609A3 (en) | Test strip composition and method to measure cholesterol from low density lipoproteins | |
EP1312919A3 (en) | Sample volume metering apparatus | |
DE602005021398D1 (de) | Bestimmung einer prognostizierten leistung eines navigationssystems | |
ES2349107T8 (es) | Método analítico e instrumento. | |
WO2008066584A3 (en) | Rapid analyte measurement assay | |
WO2005020018A3 (en) | System and method for identification of quasi-fungible goods and services, and financial instruments based thereon | |
BRPI0811536B8 (pt) | método para detectar uma cetona biologicamente ativa e método para extração | |
EP2360472A3 (en) | Methods and materials for canine breed identification | |
WO2006031963A3 (en) | Metabolite markers for weight management | |
WO2007027200A3 (en) | A method and system for generating a valuation metric based on growth data factors | |
CA2483686A1 (en) | Analytical test element comprising a network to form a capillary channel |